Found 426 articles for: "General Medical Dermatology"
Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients
July 2026 | Volume 25 | Issue 7 | Original Article | 621 | Copyright © July 2026
Background: Anticancer treatments are associated with cutaneous adverse events (cAEs) that can severely impact patients' quality of life (QoL) and interfere with treatment outcom...
Read MoreDecoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America
July 2026 | Volume 25 | Issue 7 | Original Article | 632 | Copyright © July 2026
Background: Sensitive skin syndrome (SSS) is a common self-reported condition, more prevalent in women, characterized by redness, irritation, and discomfort in response to variou...
Read MoreMyo-Inositol in Pregnancy: Implications for Acne Management
July 2026 | Volume 25 | Issue 7 | Original Article | 611 | Copyright © July 2026
Background: Acne vulgaris is common during pregnancy and presents unique therapeutic challenges due to fetal safety considerations and restrictions on conventional acne medicatio...
Read MoreCutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series
July 2026 | Volume 25 | Issue 7 | Case Reports | 659 | Copyright © July 2026
Background: Aromatase inhibitors (AIs) and anti-HER2 therapies improve breast cancer survival, but dermatologic adverse events (dAEs) are underrecognized despite affecting qualit...
Read MoreAlopecia Areata in Children and the Emerging Role of JAK Inhibitors
July 2026 | Volume 25 | Issue 7 | Features | e61 | Copyright © July 2026
ChatGPT Exhibits Reduced Sensitivity in Identifying Concern for Malignancy in Darker Skin Tones
July 2026 | Volume 25 | Issue 7 | Editorials | e64 | Copyright © July 2026
An Update on Common Genodermatoses Not to be Missed
July 2026 | Volume 25 | Issue 7 | Features | 673 | Copyright © July 2026
Update on Granulomatous Dermatoses: Clinical Features and Therapeutic Advances
June 2026 | Volume 25 | Issue 6 | Features | 580 | Copyright © June 2026
A Review of the Relationship Between Cutibacterium acnes, Biofilms, and Keratosis Pilaris
June 2026 | Volume 25 | Issue 6 | Features | e53 | Copyright © June 2026
Resolution of Hand, Foot, and Mouth Disease With Valacyclovir
June 2026 | Volume 25 | Issue 6 | Case Reports | 562 | Copyright © June 2026
Hand, foot, and mouth disease (HFMD) is a common viral illness that predominantly affects young children, with approximately 95% of cases occurring in individuals under the age of 5. While typica...
Read MoreTreatment of Seborrheic Dermatitis and Post-Inflammatory Hypopigmentation With Roflumilast Foam in Skin of Color Patients
June 2026 | Volume 25 | Issue 6 | Features | 572 | Copyright © June 2026
Formulary Coverage of Topical Rosacea Therapies in United States Commercial Insurance: A Cross-Sectional Review
June 2026 | Volume 25 | Issue 6 | Editorials | 577 | Copyright © June 2026
Time is Tissue: A Representative Case Report Highlighting the Importance of Early Clinical Diagnosis of Necrotizing Fasciitis
May 2026 | Volume 25 | Issue 5 | Features | 483 | Copyright © May 2026
Malignancy Risk in Autoimmune Blistering Disorders: A Retrospective Cohort Study
May 2026 | Volume 25 | Issue 5 | Editorials | e47 | Copyright © May 2026
Thermal Imaging for Cryotherapy Documentation in Dermatology Practice
May 2026 | Volume 25 | Issue 5 | Editorials | e45 | Copyright © May 2026
Treatment or Trigger? The Use of Biologic Therapy for Alopecia Areata
May 2026 | Volume 25 | Issue 5 | Features | 489 | Copyright © May 2026
Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib
April 2026 | Volume 25 | Issue 4 | Case Reports | 384 | Copyright © April 2026
Introduction: JAK inhibitors are increasingly being utilized for the treatment of diseases beyond their nonclassical indications, and thehighly selective JAK1 inhibi...
Read MoreExosome-Based Therapies in Dermatology: A Scoping Review
April 2026 | Volume 25 | Issue 4 | Original Article | 368 | Copyright © April 2026
Background: In pre-clinical studies, exosomes activate dermal repair mechanisms, and they may show regenerative potential for skin rejuvenation, pigmentation, scarring, hair loss...
Read MoreHydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations
April 2026 | Volume 25 | Issue 4 | Original Article | 363 | Copyright © April 2026
Hydroquinone has long served as the gold standard for hyperpigmentation treatment, but safety concerns, regulatory changes, and growing interest in non-hydroquinone therapies have prompted reeval...
Read MorePatient Interest in Dermatologists in the United States: A 20-Year Google Trends and Workforce Analysis
April 2026 | Volume 25 | Issue 4 | Original Article | 357 | Copyright © April 2026
Background: Dermatologists remain unevenly distributed throughout the United States (US), leading to disparities in access to dermatologic care.© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
